Skip to main content

Advertisement

Table 2 Cancer Incidence Rate Ratio: US/Utah rate ratio for US without Utah/Utah, by site, for males and females, 1995-2004, for those cancer sites with significantly higher, or significantly lower rates in Utah than the US

From: Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site

All Cancer Sites Utah Lower Utah Higher
Oral cavity and Pharynx 1.20 (1.19, 1.21)  
Esophagus 1.31 (1.24, 1.39)  
Stomach 1.66 (1.51, 1.82)  
Colon and Rectum 1.51 (1.41, 1.62)  
Anus 1.31 (1.27, 1.34)  
Liver and intrahepatic bile duct 1.23 (1.06, 1.44)  
Pancreas 1.89 (1.72, 2.07)  
Larynx 1.32 (1.25, 1.40)  
Lung and Bronchus 2.01 (1.80, 2.26)  
Melanoma (skin)   0.86 (0.83, 0.89)
Female breast 1.17 (1.14, 1.19)  
Cervix uteri 1.24 (1.15, 1.35)  
Corpus and uterus, NOS 1.08 (1.03, 1.13)  
Ovary 1.07 (1.01, 1.14)  
Prostate   0.95 (0.94, 0.97)
Testis   0.86 (0.79, 0.93)
Urinary bladder 1.25 (1.21, 1.30)  
Kidney and renal pelvis 1.33 (1.26, 1.40)  
Brain and other nervous system   0.94 (0.89, 0.99)
Thyroid   0.82 (0.78, 0.86)
Hodgkin's lymphoma 1.22 (1.11, 1.35)  
Non-Hodgkin's lymphoma 1.07 (1.03, 1.11)  
Myeloma 1.09 (1.02, 1.17)  
Leukemia 1.07 (1.03, 1.13)  
  1. Rates are per 100,000 and age-adjusted to the 2000 US Standard population (19 age groups - Census p 25-1130) standard; Confidence intervals are 95% for rates and ratios [22, 23].